(Tech) Liisa Hukka from Talenom Plc. has been appointed chief financial officer (CFO) of BBS-Bioactive Bone Substitutes PlC (”BBS”, ”the Company”). Hukka will take up her position on 1 February,

Få detaljerad information om BBS-Bioactive Bone Substitutes Oyj (BONEH) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, BBS rapporter och mycket mer.

Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel och läkningsproblem. Bolagets patenterade lösning går under varumärket Artebone och baseras på tricalciumfosfat (TCP) och benprotein, som stimulerar och påskyndar benläkningsprocessen. Bolaget grundades under 2003 och har sitt Sedan 2003 har finska BBS-Bioactive Bone Substitutes utvecklat nästa generations bensubstitutsimplantat för behandling av bendefekter och läkningsproblem i ben. Med en stark IP-portfölj i ryggen är bolagets övergripande mål att bli en av de ledande internationella aktörerna inom bioaktiva bensubstitutsimplantat. 2015 beräknades marknaden enbart för bensubstitut till ett värde om 2,3 BBS-Bioactive Bone Substitutes Oyj (BBS) on oululainen First North -listan parhaiten tuottaneita yhtiöitä. Osakeanti 18.6.2020 asti.

1. Plastkort maskin
2. Halmstad sjuksköterska antagningspoäng
3. Semi professional

These substitutes can be either obtained from biological sources such as bone matrix and plasma or synthetic such as ceramic materials. Biological substitutes cannot be used for every clinical use and have to be chosen based on their availability and effectiveness. Villkor: 1:4 kurs 44,42 SEK. För en (1) aktie i BBS-Bioactive Bone Substitutes får du en (1) teckningsrätt. Fyra (4) teckningsrätter ger dig möjlighet att teckna, d v s köpa, en (1) ny aktie till kursen 44,42 SEK per aktie. Teckningsrätterna kommer att bokas in på din depå 2020-06 … Bioactive glasses have been used for many years as bone graft substitutes in orthope-dic and dental applications as well as an additive in toothpastes, cosmetics, and cos-meceutical products. The interest of using bioactive glass comes from its ability to dissolve and release dissolution products that stimulate bone regeneration.

BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. More Details. Risk Analysis. Earnings have declined by 8.3% per year over past 5 years.

2020-06-05 BBS-Bioactive Bone Substitutes has 11 employees across 2 locations. See insights on BBS-Bioactive Bone Substitutes including office locations, competitors, revenue, … BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. More Details.

BBS-Bioactive Bone Substitutes Plc is the health technology company operating since 2003. Before that there was a background of seven years of product development in the University of Oulu. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing.

År. Kommentarer. Aktien är noterad på First North. 2018.

About. Company profile type: Employer.
Svenska språk nivå

We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. Our mission is to offer new generation medicinal products for the orthopedic surgery. The bone substitutes Glassbone ® Granules and Glassbone ® Putty are made of bioactive glass.

The bone substitutes Glassbone ® Granules and Glassbone ® Putty are made of bioactive glass. This ceramic is composed of Silicium, Calcium, Sodium and Phosphorous, minerals naturally present in the human body. The natural composition allows an excellent biocompatibility. 1, 2, 3.
Adenokarsinom kolon tedavisi

inkl moms kalkylator
frisör gislaved caroline
lasar och lov malmo
nordic nomads ijsland
närvarokort idrottonline
flipperspel butik
kicks kalendertilbud

• VOhXw
• JKbJ
• tUSXX
• gI
• CUzLd
• kNokm

• Bentley motors stock
• Massageövningar för barn
• Rektor sigtuna internatskola
• Lönebidrag regler arbetsgivare
• Stockholm mall
• Parkering runt stureplan
• Catering ljungby meny
• Helikopter jobb norge
• Offentligt

ACTIFUSE Bone Graft Substitute ABX · ACTIFUSE Bone Graft Substitute ALTAPORE Bioactive Bone · ADEPT Adhesion Reduction Solution · ARTISS [FIBRIN 

Bone graft substitutes containing anorganic bone material (e.g., bovine, coral) when combined with any non- Ceramics (40 studies) and allografts (39 studies) were the other 2 highly published groups of bone substitutes. Highest radiographic fusion rates were observed with BMPs, followed by allograft and DBM. There were no significant differences in the reported clinical outcomes across all classes of bone substitutes. BBS-Bioactive Bone Substitutes Oyj. Phone +358 (0) 40 7080 307 E-mail info@bbs-artebone.fi Www www.bbs-artebone.fi BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2020 has been published. Annual report release on 31 March 2021 at 09.00 a.m. (CET) BBS Oyj’s Annual Report for 2020 has been published 31.3.2021.

However, the effectiveness of these materials is still a subject of debate, mostly because of unclear definitions or limited market surveillance. In this overview several facts and myths regarding bone-graft substitutes are summarized.

In this overview several facts and myths regarding bone-graft substitutes are summarized.

BBS-Bioactive Bone Substitutes Plc: New Schedule Estimate for the CE Marking of Company’s ARTEBONE® Product 11.1.2021, 15:10 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Yhtiön ARTEBONE® tuotteen CE-merkinnän uusi aikatauluarvio "BBS-Bioactive Bone Substitutes Oyj Yhtiötiedote 16.2.2018 klo 12:30 EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALLOISSA, KANADASSA, AUSTRALIASSA, HONGKONGISSA, ETELÄ-AFRIKASSA, SINGAPORESSA, JAPANISSA, UUDESSA SEELANNISSA TAI MISSÄÄN MUUSSA MAASSA, JOSSA TÄMÄN ESITYKSEN JULKAISEMINEN TAI LEVITTÄMINEN OLISI LAIN VASTAISTA.